ICNApedia
JICNA
Forum
Wiki
Search
Help
Sign In
Register
Sign In
Your email address
Your password
Remember me
Login
I forgot my password
Home
Education
Biographical sketches
News
Educational Meetings
FLICNA Podcasts
Journal Watch
Journals TOC
Lectures
Neuroimages
Guidelines
Bookshelf
Clinical Videos
ICNApedia VLE
Media Library
Webinars
Links
Podcasts
Opportunities
Discussions
Forum
GBOD Fellowships
Research Training Fellowships
Neuroxchange
Research
About the Research Portal
ICNA Research Task Force
Junior Researcher Award
Special Interest Groups (SIG)
Researcher Tools
My Favourites
Top Tips on How to do Research
Funding opportunities
Researcher's Forum
Connectome Project
Mentorship Programme
ICNTN
ICNTN Webinars
Neurogenomics symposium
AIIMS(New Delhi)-ICNTN
ICNTN Certificate Course Modules
Learner Dashboard
Subscription Plans
Faculty Instructions
Zoom Instructions
Our Team
Contact Us
Webinars Registration
Neurology through Art and Time
Activity Stream
FLICNA
Forum
FLICNA Webinars
Congresses
ICNC2024 Cape Town
ICNC 2022 Antalya
ICNC 2020 Virtual Congress
ICNC 2018 Mumbai
ICNC 2016 Amsterdam
ICNC 2014 Iguazú
ICNC 2012 Brisbane
ICNC 2010 Cairo
Community
About the ICNA
Logo Design Contest
ICNA Zimbabwe appeal
Document Archives
Membership
Join the ICNA
My membership
Individual Registration
Organisation
ICNA Membership Benefits
My Documents
Linked Accounts
Manage subscriptions
My Favourites
My Lists
ICNApedia
JICNA
Forum
Wiki
Search
Help
Sign In
Register
Sign In
Your email address
Your password
Remember me
Login
I forgot my password
Journals TOC
The Lancet Neurology
The Lancet Neurology
7
[Articles] Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study
Saturday, 01 July 2023
0 comments
13
[Review] Palliative care to support the needs of adults with neurological disease
Saturday, 01 July 2023
0 comments
7
[Articles] Frequency of euthanasia, factors associated with end-of-life practices, and quality of end-of-life care in patients with amyotrophic lateral sclerosis in the Netherlands: a population-based cohort study
Saturday, 01 July 2023
0 comments
15
[Articles] Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trial
Saturday, 01 July 2023
0 comments
11
[Articles] Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial
Saturday, 01 July 2023
0 comments
10
[In Context] Appropriate selection of participants for clinical trials in epilepsy
Saturday, 01 July 2023
0 comments
6
[Comment] Trials in intracerebral haemorrhage: a path to success?
Saturday, 01 July 2023
0 comments
Start
Prev
1
2
3
Next
End
You are now being logged in using your Facebook credentials